Skip to content
healthcare.dev

allergy d

NDC 0113-9004, loratadine, pseudoephedrine sulfate, tablet, extended release, from L. Perrigo Company.

Product NDC
0113-9004
Status
Listed
Labeler
L. Perrigo Company
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA075989
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0113-9004 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LORATADINE10 mg/1
  • PSEUDOEPHEDRINE SULFATE240 mg/1

Pharmacologic classes

Adrenergic alpha-Agonists [MoA]; alpha-Adrenergic Agonist [EPC]

Package NDCNDC-11Package
0113-9004-220011390042215 BLISTER PACK in 1 CARTON (0113-9004-22) / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • NADAC price for package 00113900422

    GET /v1/drugs/nadac/00113900422

Use it

Look up 0113-9004 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0113-9004 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0113-9004. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.